Dr Reddys Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DR REDDYS, and when can generic versions of DR REDDYS drugs launch?
DR REDDYS has three hundred and sixty-two approved drugs.
There are two US patents protecting DR REDDYS drugs. There are twenty tentative approvals on DR REDDYS drugs.
There is one patent family member on DR REDDYS drugs in one country and seven hundred and fifty-seven supplementary protection certificates in eighteen countries.
Summary for Dr Reddys
| International Patents: | 1 |
| US Patents: | 2 |
| Tradenames: | 290 |
| Ingredients: | 263 |
| NDAs: | 362 |
Drugs and US Patents for Dr Reddys
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys | TOPIRAMATE | topiramate | CAPSULE, EXTENDED RELEASE;ORAL | 217231-003 | Nov 17, 2023 | AB1 | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Dr Reddys Labs Ltd | OLANZAPINE | olanzapine | TABLET, ORALLY DISINTEGRATING;ORAL | 076534-004 | Oct 24, 2011 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Dr Reddys | SEVELAMER CARBONATE | sevelamer carbonate | TABLET;ORAL | 206094-001 | Sep 29, 2017 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Dr Reddys Labs Inc | FLUCONAZOLE | fluconazole | TABLET;ORAL | 076658-002 | Jul 29, 2004 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Dr Reddys Labs Sa | REZIPRES | ephedrine hydrochloride | SOLUTION;INTRAVENOUS | 213536-004 | Dec 7, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| Dr Reddys Labs Ltd | FEXOFENADINE HYDROCHLORIDE ALLERGY | fexofenadine hydrochloride | TABLET;ORAL | 076502-008 | Apr 12, 2011 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Dr Reddys
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Dr Reddys Labs Sa | HABITROL | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020076-006 | Nov 12, 1999 | 5,834,011 | ⤷ Try a Trial |
| Dr Reddys Labs Sa | HABITROL | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020076-004 | Nov 12, 1999 | 5,834,011 | ⤷ Try a Trial |
| Dr Reddys Labs Sa | HABITROL | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020076-006 | Nov 12, 1999 | 5,016,652 | ⤷ Try a Trial |
| Dr Reddys Labs Sa | HABITROL | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020076-004 | Nov 12, 1999 | 4,597,961 | ⤷ Try a Trial |
| Dr Reddys Labs Sa | HABITROL | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020076-005 | Nov 12, 1999 | 5,834,011 | ⤷ Try a Trial |
| Dr Reddys Labs Sa | HABITROL | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 020076-005 | Nov 12, 1999 | 4,597,961 | ⤷ Try a Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for DR REDDYS drugs
| Drugname | Dosage | Strength | Tradename | Submissiondate |
|---|---|---|---|---|
| ➤ Subscribe | for Injection | 100 mcg/vial and 500 mcg/vial | ➤ Subscribe | 2015-04-14 |
| ➤ Subscribe | Delayed-release Tablets | 20 mg | ➤ Subscribe | 2015-06-03 |
| ➤ Subscribe | for Injection | 200 mcg/vial | ➤ Subscribe | 2015-05-01 |
International Patents for Dr Reddys Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2016005962 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Dr Reddys Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0763039 | PA2008009 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: TEMSIROLIMUSUM; REG. NO/DATE: EU/1/07/424/001 20071119 |
| 1948158 | 16C0018 | France | ⤷ Try a Trial | PRODUCT NAME: SACUBITRIL/VALSARTAN,SOUS FORME DE COMPLEXE SODIQUE SACUBITRIL VALSARTAN,C'EST-A-DIRE DE (3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3-ETHOXYCARBONYL-1-BUTYLCARBAMOYL) PROPIONATE-(S)-3'-METHYL-2'-(PENTANOY(2''-(TETRAZOL-5-YLATE)BIPHENYL-4'-YLMETHYL)AMINO)BUTYRATE)DE TRISODIUM HEMIPENTAHYDRATE; REGISTRATION NO/DATE: EU/1/15/1058 20151123 |
| 0678503 | C300499 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: COMBINATIE OMVATTEND ALISKIREN OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN, EN AMLODIPINE OF EEN FARMACEUTISCH AANVAARDBAAR ZOUT DAARVAN; REGISTRATION NO/DATE: EU/1/11/686/001-056 20110114 |
| 1667986 | PA2013010 | Lithuania | ⤷ Try a Trial | PRODUCT NAME: CABAZITAXELUM; REGISTRATION NO/DATE: EU/1/11/676/001 20110317 |
| 2962690 | C201930044 | Spain | ⤷ Try a Trial | PRODUCT NAME: APREMILAST O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO; NATIONAL AUTHORISATION NUMBER: EU/1/14/981; DATE OF AUTHORISATION: 20150115; NUMBER OF FIRST AUTHORISATION IN EUROPEAN ECONOMIC AREA (EEA): EU/1/14/981; DATE OF FIRST AUTHORISATION IN EEA: 20150115 |
| 1948158 | 1690020-1 | Sweden | ⤷ Try a Trial | PRODUCT NAME: SACUBITRIL AND VALSARTAN, AS SACUBITRIL VALSARTAN SODIUM SALT COMPLEX, I.E. TRISODIUM 3-((1S,3R)-1-BIPHENYL-4-YLMETHYL-3- ETHOXYCARBONYL-1-BUTYLCARBAMOYL)PROPIONATE-(S)-3-METHYL-2- (PENTANOYL2-(TETRAZOL-5-YLATE)BIPHENYL-4- YLMETHYLAMINO)BUTYRATE HEMIPENTAHYDRATE; REG. NO/DATE: EU/1/15/1058 20151123 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
